NO995182L - Pattedyrcytokinlignende faktor 7 - Google Patents

Pattedyrcytokinlignende faktor 7

Info

Publication number
NO995182L
NO995182L NO995182A NO995182A NO995182L NO 995182 L NO995182 L NO 995182L NO 995182 A NO995182 A NO 995182A NO 995182 A NO995182 A NO 995182A NO 995182 L NO995182 L NO 995182L
Authority
NO
Norway
Prior art keywords
factor
mammalian cytokine
polypeptides
mammalian
cytokine
Prior art date
Application number
NO995182A
Other languages
English (en)
Other versions
NO995182D0 (no
Inventor
Scott R Presnell
Teresa Gilbert
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of NO995182D0 publication Critical patent/NO995182D0/no
Publication of NO995182L publication Critical patent/NO995182L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Radar Systems Or Details Thereof (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
NO995182A 1997-04-25 1999-10-22 Pattedyrcytokinlignende faktor 7 NO995182L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4488697P 1997-04-25 1997-04-25
US84575397A 1997-04-25 1997-04-25
US7167698P 1998-01-16 1998-01-16
US854398A 1998-01-16 1998-01-16
PCT/US1998/008212 WO1998049310A1 (en) 1997-04-25 1998-04-23 Mammalian cytokine-like factor 7

Publications (2)

Publication Number Publication Date
NO995182D0 NO995182D0 (no) 1999-10-22
NO995182L true NO995182L (no) 1999-12-22

Family

ID=27485789

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995182A NO995182L (no) 1997-04-25 1999-10-22 Pattedyrcytokinlignende faktor 7

Country Status (16)

Country Link
EP (1) EP0977861B1 (no)
JP (1) JP4216343B2 (no)
KR (1) KR20010012111A (no)
CN (1) CN1258315A (no)
AT (1) ATE269901T1 (no)
AU (1) AU736362B2 (no)
BR (1) BR9809778A (no)
CA (1) CA2288360A1 (no)
DE (1) DE69824719T2 (no)
EA (1) EA199900869A1 (no)
ES (1) ES2223127T3 (no)
IL (1) IL132496A0 (no)
NO (1) NO995182L (no)
NZ (1) NZ500885A (no)
PL (1) PL336470A1 (no)
WO (1) WO1998049310A1 (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6579520B2 (en) 1998-05-15 2003-06-17 Genentech, Inc. IL-17 related mammalian cytokine polypeptides (IL-17E)
US6569645B2 (en) 1999-05-14 2003-05-27 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
US6486301B1 (en) 1997-07-16 2002-11-26 Human Genome Sciences, Inc. Interleukin-20
WO1999003982A1 (en) * 1997-07-16 1999-01-28 Human Genome Sciences, Inc. Interleukin-20
US6562578B1 (en) 1999-01-11 2003-05-13 Schering Corporation IL-17-like cytokine binding compounds and antibodies
WO1999035267A1 (en) * 1998-01-09 1999-07-15 Immunex Corporation Human and murine il-17d, cytokine related to interleukin-17: dna and polypeptides
EP1865061A3 (en) * 1998-05-15 2007-12-19 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
EP3112468A1 (en) * 1998-05-15 2017-01-04 Genentech, Inc. Il-17 homologous polypeptides and therapeutic uses thereof
US7771719B1 (en) 2000-01-11 2010-08-10 Genentech, Inc. Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
AU740405B2 (en) * 1998-05-15 2001-11-01 Genentech Inc. IL-17 homologous polypeptides and therapeutic uses thereof
JP2002525056A (ja) * 1998-09-17 2002-08-13 ザイモジェネティクス，インコーポレイティド 哺乳類のトランスフォーミング増殖因子β−９
PT1141297E (pt) * 1999-01-11 2010-01-06 Schering Corp Citoquinas de mamíferos relacionadas com a interleucina-17. polinucleótidos que as codificam. utilizações
JP2003521239A (ja) * 1999-04-09 2003-07-15 キュラジェン コーポレイション 新規ヒトタンパク質およびそれらをコードするポリヌクレオチド
CA2391374A1 (en) * 1999-12-23 2001-06-28 Genentech, Inc. Il-17 homologous polypeptides and therapeutic uses thereof
US20040043397A1 (en) 2000-01-11 2004-03-04 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
JP2016047051A (ja) * 1999-12-23 2016-04-07 ジェネンテック， インコーポレイテッド Ｉｌ−１７相同的ポリペプチドとその治療上の用途
EP1259253A2 (en) * 2000-02-29 2002-11-27 ZymoGenetics, Inc. Methods for promoting production of myelin by schwann cells
US6569419B2 (en) 2000-02-29 2003-05-27 Zymogenetics, Inc. Methods for promoting production of myelin by Schwann cells
US7718397B2 (en) 2000-03-21 2010-05-18 Genentech, Inc. Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
US20030096969A1 (en) 2000-06-02 2003-05-22 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2002305053A1 (en) * 2001-03-26 2002-10-08 University Of Washington Method of inducing proliferation of retinal stem cells
BR0205083A (pt) * 2001-04-20 2004-07-20 Zymogenetics Inc Polipeptìdeo isolado, composição farmacêutica, proteìna de fusão, polinucleotìdeo isolado, vetor de expressão, célula hospedeira recombinante e métodos de produzir um polipeptìdeo, de detectar a presença da expressão de gene em uma amostra biológica, de expandir células monocìticas ou progenitores de células de monócitos e de estimular uma resposta imune em um mamìfero exposto a um antìgeno ou patógeno
US20070053872A1 (en) * 2005-08-04 2007-03-08 Moore Emma E Treatment of wounds using il-17b
JP2010509364A (ja) * 2006-11-08 2010-03-25 ザイモジェネティクス， インコーポレイテッド 創傷治癒における使用のためのｉｌ−１７ｂ
CA2721713C (en) 2008-05-05 2019-07-09 Novimmune Sa Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
EP2427203B1 (en) 2009-05-05 2018-10-17 Novimmune S.A. Anti-il-17f antibodies and use thereof

Also Published As

Publication number Publication date
BR9809778A (pt) 2000-06-20
JP2002509432A (ja) 2002-03-26
ES2223127T3 (es) 2005-02-16
NO995182D0 (no) 1999-10-22
ATE269901T1 (de) 2004-07-15
EP0977861A1 (en) 2000-02-09
WO1998049310A1 (en) 1998-11-05
CA2288360A1 (en) 1998-11-05
IL132496A0 (en) 2001-03-19
KR20010012111A (ko) 2001-02-15
EA199900869A1 (ru) 2000-12-25
DE69824719T2 (de) 2005-06-30
DE69824719D1 (de) 2004-07-29
AU7152798A (en) 1998-11-24
JP4216343B2 (ja) 2009-01-28
PL336470A1 (en) 2000-06-19
CN1258315A (zh) 2000-06-28
AU736362B2 (en) 2001-07-26
NZ500885A (en) 2001-06-29
EP0977861B1 (en) 2004-06-23

Similar Documents

Publication Publication Date Title
NO995182D0 (no) Pattedyrcytokinlignende faktor 7
TR199501229A2 (tr) Yeni bilesim.
IT9048444A0 (it) Composizione disperdente per cemento.
FI915135L (fi) Nya cyklosporiner.
NO20002800D0 (no) Cyklosporinholdig mikroemulsjon, forkonsentratsammensetning
DK2302027T3 (da) Alfa-amylasemutanter
FI912086L (fi) Polypeptider.
PT904060E (pt) Composicoes antifungicas com biodisponibilidades melhorada
DE69000504D1 (de) Ori-gehemmte motorkraftstoffzusammensetzung.
WO2000015798A3 (en) Mammalian transforming growth factor beta - 9 (ztgfss9)
WO1998057983A3 (en) Mammalian neuro-growth factor like protein
DK0901488T3 (da) 2,4-diaminopyrimidinderivater
DE69836697D1 (de) Neue 3,6-Hemiketale der 9a-Azalidklasse
ATE304561T1 (de) Haarfestigerzusammensetzung enthaltend linear verstärkte siliconpfropfpolymere
DE69634489D1 (de) Adenovirus dodekahedrischer proteinkomplex, dieser enthaltende zusammensetzung und verwendungen davon
DE69825133D1 (de) Feste Brennstoffzusammensetzung
DE69114184D1 (de) Harzzusammensetzung für Grundierung und Grundierungsmittel davon.
DE68900847D1 (de) Dispergiermittelzusammensetzung fuer zement.
DE69938130D1 (de) Neue peptide
DE69130845D1 (de) HLA-DR Antigen-Gen, dessen Nukleotidsequenz und Verwendung
WO1999029720A3 (en) Mammalian alpha helical protein-1
DE69005136D1 (de) Grundierungszusammensetzung.
NL1001774A1 (nl) Harssamenstelling.
BR9808514A (pt) Proteìnas quiméricas do ligante flt3
FI891208A7 (fi) Elektriskt styrd blandningskran.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application